Aon plc · AON · FY2026 Q3 · Calendar Q4 2026
Aon Q3: 6% organic growth; USI close and synergies in focus
Aon's quarter supports a constructive view of resilient demand and operating leverage, but the next leg of the story depends on executing the USI integration while managing reinsurance pricing and investment-income pressure.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about AON FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management described stronger organic growth across the business, continued momentum in reinsurance and construction, and a clearer integration plan for the pending USI acquisition. The emphasis shifted toward executing identified synergies, deleveraging and scaling AI-enabled analytics.
Guidance delta
Maintained. Management kept its existing full-year outlook while emphasizing disciplined capital allocation, deleveraging and continued reinvestment.
Key takeaways
- Organic growth remained resilient despite macro volatility.
- Aon United and AI-enabled analytics remain central to cross-selling, differentiation and operating leverage.
- USI integration is the principal execution milestone, with management outlining synergy work streams and a planned Q4 close.
- Reinsurance, construction and middle-market activity were highlighted as important growth areas.
Management priorities
- Close and integrate USI while executing the identified synergy work streams.
- Expand Aon United and AI-driven analytics globally.
- Hire priority revenue-generating talent and invest in technology and shared services.
- Balance deleveraging, dividend support, strategic reinvestment and shareholder returns.
Follow AON with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 2, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 1, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Sep 1, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| B of A Securities | Outperform | Neutral | Upgrade | Feb 27, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jul 30, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | May 13, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 3, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Oct 5, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 13, 2023 |
| MKM Partners | Buy | Buy | Maintain | Dec 5, 2022 |
| Raymond James | Underperform | Market Perform | Downgrade | Oct 31, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 4, 2021 |
| William Blair | Perform | Outperform | Downgrade | Nov 25, 2020 |
| Stifel Nicolaus | Perform | Market Perform | Maintain | Nov 25, 2020 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 25, 2020 |
| Sandler O'Neill | Buy | Hold | Upgrade | Nov 25, 2020 |
| Nomura | Neutral | Neutral | Maintain | Nov 25, 2020 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Nov 25, 2020 |
| Janney Capital | Neutral | Buy | Downgrade | Nov 25, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Nov 25, 2020 |
| CFRA | Buy | Buy | Maintain | Nov 25, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Nov 25, 2020 |
| Compass Point | Buy | Buy | Maintain | Jan 15, 2019 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 21, 2017 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 21, 2015 |
| Stifel | Market Perform | Market Perform | Maintain | Aug 3, 2015 |
| PiperJaffray | Neutral | Neutral | Maintain | Jun 4, 2015 |
| Evercore Partners | Overweight | Overweight | Maintain | Jul 10, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $315.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Elyse Greenspan | $323 | $273.47 | +2.3% | Oct 12, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $400 | $273.99 | +26.7% | Oct 7, 2026 |
| Mizuho Securities | Analyst unavailable | $324 | $273.99 | +2.6% | Oct 7, 2026 |
| Barclays | Analyst unavailable | $317 | $273.99 | +0.4% | Oct 7, 2026 |
| Morgan Stanley | Bob Huang | $350 | $271.93 | +10.9% | Oct 6, 2026 |
| Mizuho Securities | Analyst unavailable | $366 | $304.67 | +15.9% | Sep 16, 2026 |
| Evercore ISI | David Motemaden | $423 | $327.48 | +34.0% | Sep 2, 2026 |
| BMO Capital | Michael Zaremski | $360 | $321.03 | +14.0% | Sep 1, 2026 |
| Roth Capital | Analyst unavailable | $380 | $321.52 | +20.4% | Sep 1, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $433 | $321.52 | +37.1% | Sep 1, 2026 |
| Piper Sandler | Paul Newsome | $349 | $321.52 | +10.5% | Sep 1, 2026 |
| Wells Fargo | Analyst unavailable | $383 | $321.52 | +21.3% | Sep 1, 2026 |
| Morgan Stanley | Analyst unavailable | $410 | $343.2 | +29.9% | Aug 19, 2026 |
| UBS | Brian Meredith | $387 | $360.55 | +22.6% | Aug 3, 2026 |
| Roth Capital | Analyst unavailable | $420 | $361.22 | +33.0% | Jul 31, 2026 |
| Piper Sandler | Analyst unavailable | $391 | $377.16 | +23.8% | Jul 30, 2026 |
| Piper Sandler | Analyst unavailable | $377 | $358.89 | +19.4% | Jul 15, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $445 | $355.17 | +40.9% | Jul 9, 2026 |
| Mizuho Securities | Yaron Kinar | $426 | $357.51 | +34.9% | Jul 9, 2026 |
| UBS | Analyst unavailable | $383 | $359.29 | +21.3% | Jul 8, 2026 |
| Barclays | Analyst unavailable | $382 | $356.91 | +21.0% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $380 | $357.46 | +20.4% | Jul 6, 2026 |
| UBS | Analyst unavailable | $360 | $329.51 | +14.0% | Jun 16, 2026 |
| Piper Sandler | Analyst unavailable | $355 | $335.31 | +12.4% | Jun 15, 2026 |
| Piper Sandler | Paul Newsome | $360 | $324.78 | +14.0% | May 26, 2026 |
| Morgan Stanley | Bob Huang | $370 | $321.15 | +17.2% | May 21, 2026 |
| Piper Sandler | Analyst unavailable | $388 | $311.51 | +22.9% | May 4, 2026 |
| Mizuho Securities | Yaron Kinar | $394 | $318.03 | +24.8% | Apr 13, 2026 |
| Mizuho Securities | Yaron Kinar | $398 | $349.61 | +26.1% | Feb 3, 2026 |
| Jefferies | Andrew Andersen | $408 | $351.99 | +29.2% | Feb 2, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $412 | $351.99 | +30.5% | Feb 2, 2026 |
| UBS | Analyst unavailable | $385 | $349.64 | +21.9% | Feb 2, 2026 |
| Wells Fargo | Elyse Greenspan | $443 | $349.64 | +40.3% | Feb 1, 2026 |
| Mizuho Securities | Analyst unavailable | $387 | $344.59 | +22.6% | Jan 14, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $393 | $344.59 | +24.5% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $448 | $350.49 | +41.9% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $381 | $349.92 | +20.7% | Jan 8, 2026 |
| Goldman Sachs | Analyst unavailable | $395 | $349.92 | +25.1% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $436 | $344.63 | +38.1% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $400 | $353.71 | +26.7% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $389 | $353.71 | +23.2% | Dec 15, 2025 |
| Barclays | Alex Scott | $379 | $344.17 | +20.0% | Nov 20, 2025 |
| Roth Capital | Harry Fong | $390 | $340.8 | +23.5% | Nov 4, 2025 |
| Evercore ISI | Analyst unavailable | $435 | $339.42 | +37.8% | Nov 3, 2025 |
| Evercore ISI | David Motemaden | $427 | $354.64 | +35.2% | Oct 1, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $440 | $363.81 | +39.4% | Aug 12, 2025 |
| Barclays | Analyst unavailable | $420 | $352.91 | +33.0% | Jul 31, 2025 |
| Redburn Partners | Daniel Sykes | $445 | $396.14 | +40.9% | Mar 25, 2025 |
| BMO Capital | Michael Zaremski | $380 | $365.64 | +20.4% | Nov 4, 2024 |
| Goldman Sachs | Robert Cox | $390 | $371.71 | +23.5% | Oct 28, 2024 |
| Wells Fargo | Elyse Greenspan | $377 | $371.84 | +19.4% | Oct 28, 2024 |
| Jefferies | Yaron Kinar | $365 | $353.97 | +15.6% | Oct 9, 2024 |
| Barclays | Alex Scott | $394 | $348.55 | +24.8% | Sep 4, 2024 |
| Piper Sandler | Paul Newsome | $335 | $323 | +6.1% | Jul 29, 2024 |
| Morgan Stanley | Bob Huang | $323 | $323 | +2.3% | Jul 26, 2024 |
| Evercore ISI | David Motemaden | $338 | $323 | +7.1% | Jul 26, 2024 |
| Morgan Stanley | Bob Huang | $296 | $293.16 | -6.2% | Jul 10, 2024 |
| Wells Fargo | Elyse Greenspan | $287 | $293.49 | -9.1% | Jul 2, 2024 |
| BMO Capital | Michael Zaremski | $325 | $293.58 | +2.9% | Jun 28, 2024 |
| RBC Capital | Scott Heleniak | $315 | $283.14 | -0.2% | Apr 29, 2024 |
| Piper Sandler | Paul Newsome | $312 | $282.08 | -1.2% | Apr 29, 2024 |
| Citigroup | Analyst unavailable | $340 | $320.45 | +7.7% | Feb 8, 2023 |
| Credit Suisse | Analyst unavailable | $363 | $315.87 | +15.0% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $339 | $306.14 | +7.4% | Dec 15, 2022 |
| MKM Partners | Analyst unavailable | $360 | $308.89 | +14.0% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $255 | $302.05 | -19.2% | Nov 22, 2022 |
| Wells Fargo | Elyse Greenspan | $310 | $280.78 | -1.8% | May 2, 2022 |
| Evercore ISI | David Motemaden | $292 | $273.45 | -7.5% | Jan 14, 2022 |
| Deutsche Bank | Phil Stefano | $245 | $250.95 | -22.4% | May 25, 2021 |
Track every rating change on AON the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAon plc operates as a professional services firm in the United States, rest of the Americas, the United Kingdom, Ireland, rest of Europe, the Middle East, Africa, and the Asia Pacific. It operates through Risk Capital and Human Capital segments. The company offers commercial risk solutions comprising retail and insurance brokerage, specialty solutions, global risk consulting, captives management, and affinity programs; health solutions, such as consulting and brokerage, consumer benefits, and talent advisory services; and wealth solutions, including retirement consulting and investments.…
Historical context
All AON earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| UMBF UMB Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.6% | -1.1% | UMB Financial: Strong Q3, Eldorado Deal Adds Low-Cost Deposits |
| ACGLN Arch Capital Group Ltd. | FY2026 Q3 · Calendar Q4 2026 | +15.6% | -0.9% | Arch Capital posts strong underwriting, keeps capital returns high |
| RNR RenaissanceRe Holdings Ltd. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | -2.6% | RenaissanceRe: Strong underwriting, investment volatility clouds book value |
| RNR-PG RenaissanceRe Holdings Ltd. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | — | RenaissanceRe Q3: Strong returns, higher investment income |
| ACGL Arch Capital Group Ltd. | FY2026 Q3 · Calendar Q4 2026 | +15.6% | +1.8% | Arch Capital posts strong Q3 underwriting and returns $1.4B via buybacks |
| ACGLO Arch Capital Group Ltd. | FY2026 Q3 · Calendar Q4 2026 | +15.6% | -0.2% | Arch Capital posts strong Q3 underwriting; growth remains measured |
Latest beats and misses
Who reports nextBeat on EPS
- EXEFY2026 Q3 · October 27, 2026+13.2% EPS-3.2% move
- CRFY2026 Q3 · October 27, 2026+12.6% EPS+2.9% move
- PPGFY2026 Q3 · October 27, 2026+6.1% EPS+4.4% move
- UMBFFY2026 Q3 · October 27, 2026+10.6% EPS-1.1% move
- UHSFY2026 Q3 · October 27, 2026+0.6% EPS-2.9% move
- ACGLNFY2026 Q3 · October 27, 2026+15.6% EPS-0.9% move
Get the AON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-28T16:05:24.935529+00:00
- FN2 earnings calendar · 2026-10-28T01:23:13.546025+00:00
- Polygon adjusted daily market bars · 2026-10-29T00:00:43.912699+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-29T00:00:43.910010+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-29. For educational purposes only; not investment advice.